Abstract: Objective: to evaluate the efficacy and safety of ultrasound ablation of pulmonary veins for treatment of paroxysmal atrial fibrillation. Methods: The study population consisted of 9 patients with 5 males and 4 females enrolled consecutively who had idiopathic paroxysmal atrial fibrillation(AF) . The ultrasound balloon was positioned through a special sheath to the orifice of the target vein by a transseptal procedure. The balloon was inflated with contrast-mixed saline (contrast: saline = 1:4) whose volume was decided by the diameter of the target pulmonary vein. The ablation energy was usually set up at 35 to 40 watts with temperature controlled at 60~ . The duration of each ablation was about 120 seconds which was repeated not over 10 times. Results: The average duration of the total procedure was 132 + 68 min for our patients. The average fluoroscopy time was 33 + 17 rain. With a mean follow-up of 16 • 8 months after the procedure, AF was completely eliminated in 4 patients without antiarrhythmic drugs. The episodes of atrial fibrillation were eliminated in 2 patients with low dosage of oral amiodarone (0.1, once daily) which was ineffective before the procedure. The frequency of episodes was similar to that before the procedure in 3 patients. There were no complications such as hemopericardium, air embolism and stenosis of the pulmonary veins by angiography, related to the procedure. Conclusion : Ultrasound ablation of the pulmonary veins is a new approach to treat paroxysmal atrial fibrillation. Before we determined its value, we need to do more researches with bigger sample, randomization and comparison design.
INTRODUCTION
Most paroxysmal atrial fibrillation is activated by atrial ectopies originating in the pulmonary veins. Several researches demonstrated that almost 50% of focal atrial fibrillation originates in the left superior pulmonary vein and about 30 % in the right superior pulmonary vein (Haissaguerre et al., 1998; Chen et al., 1999) .
Radiofrequency ablation has been used to isolate the conductivity of pulmonary vein potential or eliminate the potential. However, the procedure was limited by a high percentage of recurrence and unknown frequency of stenosis of the pulmonary veins (Haissaguerre et al. , 1998; Chen et al., 1999) . Initial animal studies demonstrated that the ultrasound ablation of pulmonary veins may be a safer procedure with acceptable successful rate than radiofrequency catheter ablation. During the last year, we followed up 9 patients on whom we inplemented uhrasound ablation of the pulmonary veins for treatment of paroxysmal atrial fibrillation. The results are reported here.
METHODS

Patient selection
The study population consisted of 9 patients with 5 males and 4 females enrolled consecutively (Table 1 ) who met the following criteria: having idiopathic atria] fibrillation resistant to more than two drugs and at least 2 episodes of atrial fibrillation every week, and providing consent form. The average age of the population was 53.4 + 5.2 years. Except 2 patients with mild primary hypertension, there were no overt heart disease in the other 7 patients. The average duration of atrial fibrillation was 4.3 + 3.7 years in the patients.
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E l e c t r o p h y s i o l o g i c a l study a n d u l t r a s o u n d ablation p r o c e d u r e
Two m u l t i e l e c t r o d e c a t h e t e r s were i n t r o d u c e d p e r c u t a n e o u s l y through the f e m o r a l v e i n s : one c a t h e t e r in the c o r o n a r y s i n u s a n d the o t h e r in the right v e n t r i c u l a r a p e x . Q u a d r i p o l a r roving a b l a t i o n c a t h e t e r with a t h e r m o c o u p ] e or an A-focus c i r c u l a r m a p p i n g c a t h e t e r was i n t r o d u c e d to the p u l m o n a r y v e i n s by t r a n s s e p t a l way through left the N o . 1 Swartz s h e a t h for m a p p i n g the p u lm o n a r y v e i n m u s c l e p o t e n t i a l s .
A s p e c i a l s h e a t h for the u l t r a s o u n d b a l l o o n was i n t r o d u c e d along a two a n d h a l f -c i r c l e wire to the t a r g e t vein a n d t h e n the b a l l o o n was p o s it i o n e d t h r o u g h the s h e a t h at the orifice of the target v e i n . T h e b a l l o o n was i n f l a t e d with contrastm i x e d s a l i n e ( c o n t r a s t : s a l i n e = 1 : 4 ) whose v o l u m e was d e c i d e d by the d i a m e t e r of the target p u l m o n a r y v e i n . A f t e r the b a l l o o n was fixed in the o s t i u m of the p u l m o n a r y v e i n , angiogTaphy of the p u l m o n a r y v e i n was clone t h r o u g h the s h e a t h to view the i m a g e of the b a l l o o n to m a k e sure it was a t t a c h e d very tightly to the wall ( F i g . 1 ) . T h e n , the b a l l o o n c a t h e t e r was c o n n e c t e d to the I B I -2 0 0 0 u l t r a s o u n d g e n e r a t o r . T h e a b l a t i o n e nergy was u s u a l l y set up at 35 to 4 0 watts with t e m p e r a t u r e c o n t r o l l e d at 60 ~ . T h e d u r a t i o n of e a c h a b l a t i o n was about 120 s e c o n d s . The a b l ation was u s u a l l y r e p e a t e d at one target point for 3 t i m e s a n d t h e n the e l e e t r o p h y s i o l o g i c a l m a p p i n g LIPV: left inferior pulmonary vein was r e p e a t e d ( F i g s . 2 a a n d 2 b ) .
If the m u s c l e p o t e n t i a l s p i k e s still e x i s t e d or were not i s o l a t e d , the a b l a t i o n s w o u l d b e r e p e a t e d for an o t h e r 3 t i m e s . At one t a r g e t e d p o i n t , the a b l a t i o n was u s u a l l y not r e p e a t e d o v e r 10 t i m e s . H o w e v e r , the right lower p u l m o n a r y v e i n was not a b l a t e d in all c a s e s b e c a u s e the u l t r a s o u n d b a l l o o n was too stiff to e n t e r the right lower p u l m o n a r y v e i n . 
